The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to lateral flow assays market will
help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of
67.19% in
2023.
Horizon Databook has segmented the Europe lateral flow assays market based on kits & reagents, lateral flow readers covering the revenue growth of each sub-segment from 2018 to
2030.
- Europe Lateral Flow Assays Product Outlook (Revenue, USD Million, 2018-2030)
- Kits & Reagents
- Lateral Flow Readers
- Benchtop Readers
- Digital Readers
- Europe Lateral Flow Assays Application Outlook (Revenue, USD Million, 2018-2030)
- Clinical Testing
- Infectious Disease Testing
- COVID-19
- Mosquito Borne Disease Testing
- Influenza Testing
- Sexually Transmitted Infection Testing
- HIV Testing
- HPV Testing
- Chlamydia Testing
- Gonorrhea Testing
- Syphilis Testing
- Other STI Testing
- Hepatitis
- Tuberculosis
- Other Infectious Diseases
- Cardiac Marker Testing
- Troponin I and T Testing
- CK-MB Testing
- BNP and NT-Probnp Testing
- Myoglobin Testing
- D-Dimer Testing
- Other Cardiac Marker Tests
- Pregnancy & Fetility Testing
- Pregnancy Testing
- Fertility Testing
- Cholesterol Testing/Lipid Profile
- Drugs of Abuse Testing
- Other Clinical Tests
- Veterinary Diagnostics
- Food Safety & Environment Testing
- Drug Development & Quality Testing
- Europe Lateral Flow Assays Technique Outlook (Revenue, USD Million, 2018-2030)
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
- Europe Lateral Flow Assays End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care
- Pharmaceutical & Biotechnology Companies
- Others
- Europe Lateral Flow Assays Test Type Outlook (Revenue, USD Million, 2018-2030)
- Lateral Flow Immunoassay
- Nucleic Acid Lateral Flow Assay
Reasons to
subscribe to Europe lateral flow assays market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Europe lateral flow assays market databook
-
Our clientele includes a mix of lateral flow assays market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
continent-level
data and insights on the Europe lateral flow assays market , including
forecasts for subscribers. This
continent
databook contains high-level insights into
Europe lateral flow assays market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.